Ventricular assist device therapy for heart failure-past, present, and future

International Anesthesiology Clinics

Volumn 50, Issue 3, 2012, Pages 123-145

  Bellumkonda, Lavanya ^a,b   Bonde, Pramod ^b  

^a Division of Cardiology   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLEEDING TENDENCY; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CIRCULATION; EMERGENCY CARE; EXTRACORPOREAL OXYGENATION; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART ASSIST DEVICE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER DYSFUNCTION; MENTAL DISEASE; MITRAL VALVE COMMISSUROTOMY; MORBIDITY; MYOCARDITIS; OUTCOME ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE CARE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RESTRICTIVE CARDIOMYOPATHY; SEPSIS; STROKE; THROMBOEMBOLISM; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT REFUSAL; VASODILATATION;

CARDIOTONIC AGENTS; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; PERIOPERATIVE CARE; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84863330332     PISSN: 00205907     EISSN: 15371913     Source Type: Journal    
DOI: 10.1097/AIA.0b013e31826233a9     Document Type: Article

References (25)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation. 2010;121: E46-e215.
2. Frazier OH. Prologue: Ventricular assist devices and total artificial hearts. A historical perspective. Cardiology Clin. 2003;21:1-13.
3. Bartlett RH. Extracorporeal life support: History and new directions. ASAIO J. 2005;51:487-489.
4. Delgado DH, Rao V, Ross HJ, et al. Mechanical circulatory assistance: State of art. Circulation. 2002;106:2046-2050.
5. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med. 2007;357:885-896.
6. Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N. Engl. J. Med. 2004;351:859-867.
7. Wassenberg PA. The Abiomed BVS 5000 biventricular support system. Perfusion. 2000;15:369-371.
8. Anderson M, Smedira N, Samuels L, et al. Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann Thorac Surg. 2010;90: 706-712.
9. Tsukui H, Teuteberg JJ, Murali S, et al. Biventricular assist device utilization for patients with morbid congestive heart failure: A justifiable strategy. Circulation. 2005;112:I65-I72.
10. Dowling RD, Park SJ, Pagani FD, et al. HeartMate VE LVAS design enhancements and its impact on device reliability. European J Cardio-Thorac Surg. 2004;25:958-963.
11. Jassawalla JS, Daniel MA, Chen H, et al. In vitro and in vivo testing of a totally implantable left ventricular assist system. ASAIO Trans. 1988;34:470-475.
12. Pristas JM, Borovetz HS, Kormos RL, et al. Biomedical engineering management of Novacor left ventricular assist system (LVAS) patients. Perfusion. 1990;5:181-191.
13. Arabia FA, Smith RG, Rose DS, et al. Success rates of long-Term circulatory assist devices used currently for bridge to heart transplantation. ASAIO J. 1996;42: M542-M546.
14. Mehta SM, Pae WE Jr, Rosenberg G, et al. The LionHeart LVD-2000: A completely implanted left ventricular assist device for chronic circulatory support. Ann Thorac Surg. 2001;71:S156-S161.
15. Pae WE, Connell JM, Adelowo A, et al. Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe. J Heart Lung Transplant. 2007;26:219-229.
16. Dowling PD, Etoch SW, Stevens KA, et al. Current status of the AbioCor implantable replacement heart. Ann Thorac Surg. 2001;71:S147-S149.
17. Frazier OH, Dowling RD, Gray LA Jr, et al. The total artificial heart: Where we stand. Cardiology. 2004;101:117-121.
18. DeVries WC, Anderson JL, Joyce LD, et al. Clinical use of the total artificial heart. N. Engl. J. Med. 1984;310:273-278.
19. Griffith BP, Kormos RL, Borovetz HS, et al. HeartMate II left ventricular assist system: From concept to first clinical use. Ann Thorac Surg. 2001;71(3 suppl): S116-S120.
20. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med. 2009;361:2241-2251.
21. Larose JA, Tamez D, Ashenuga M, et al. Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J. 2010;56:285-289.
22. Noon GP, Morley D, Irwin S, et al. Development and clinical application of the MicroMed DeBakey VAD. Curr Opin Cardiol. 2000;15:166-171.
23. Salzberg S, Lachat M, Zünd G, et al. Left ventricular assist device as bridge to heart transplantation-lessons learned with the MicroMed DeBakey axial blood flow pump. Eur J Cardio-Thorac Surg. 2003;24:113-118.
24. Frazier OH, Shah NA, Myers TJ, et al. Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology. 2004;101:111-116.
25. Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-39.